Atlas Trials

Assessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain Reaction

Clinical trial NCT06211166 · RECRUITING

Trial details

NCT number
NCT06211166
Sponsor
Peking University People's Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Acute LeukemiaMDSMDS/MPNCML
Start date
2024-01-08
Primary completion
2025-12-31
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.